The landscape of dementia diagnosis has progressed dramatically with the arrival of sophisticated biomarkers, like amyloid PET scans, tau imaging, and blood-based exams which can detect Alzheimer's pathology many years ahead of signs or symptoms arise. Though these technological advances signify impressive progress in knowledge neurodegenerative he